304 related articles for article (PubMed ID: 27592118)
1. Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Ricci C; Santini D; Brighi N; Fazio N; Colao A; Ferone D; Tomassetti P
Endocrine; 2017 Jun; 56(3):633-638. PubMed ID: 27592118
[TBL] [Abstract][Full Text] [Related]
2. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal.
Vannella L; Lahner E; Annibale B
World J Gastroenterol; 2012 Mar; 18(12):1279-85. PubMed ID: 22493541
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Predictors of Gastric Neoplastic Lesions in Corpus-Restricted Atrophic Gastritis: A Single-Center Cohort Study.
Dilaghi E; Dottori L; Pivetta G; Dalla Bella M; Esposito G; Ligato I; Pilozzi E; Annibale B; Lahner E
Am J Gastroenterol; 2023 Dec; 118(12):2157-2165. PubMed ID: 37207305
[TBL] [Abstract][Full Text] [Related]
4. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions.
Vanoli A; La Rosa S; Luinetti O; Klersy C; Manca R; Alvisi C; Rossi S; Trespi E; Zangrandi A; Sessa F; Capella C; Solcia E
Hum Pathol; 2013 Sep; 44(9):1827-37. PubMed ID: 23642738
[TBL] [Abstract][Full Text] [Related]
5. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
6. Combined adenocarcinoma and carcinoid tumor in atrophic gastritis.
Adhikari D; Conte C; Eskreis D; Urmacher C; Ellen K
Ann Clin Lab Sci; 2002; 32(4):422-7. PubMed ID: 12458898
[TBL] [Abstract][Full Text] [Related]
7. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
8. Development of type I gastric carcinoid in patients with chronic atrophic gastritis.
Vannella L; Sbrozzi-Vanni A; Lahner E; Bordi C; Pilozzi E; Corleto VD; Osborn JF; Delle Fave G; Annibale B
Aliment Pharmacol Ther; 2011 Jun; 33(12):1361-9. PubMed ID: 21492197
[TBL] [Abstract][Full Text] [Related]
9. Gastric cancer in chronic atrophic gastritis. Associated gastric ulcer adds no further risk.
Testoni PA; Masci E; Marchi R; Guslandi M; Ronchi G; Tittobello A
J Clin Gastroenterol; 1987 Jun; 9(3):298-302. PubMed ID: 3611683
[TBL] [Abstract][Full Text] [Related]
10. Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study.
Panzuto F; Campana D; Massironi S; Faggiano A; Rinzivillo M; Lamberti G; Sciola V; Lahner E; Manuzzi L; Colao A; Annibale B
Dig Liver Dis; 2019 Oct; 51(10):1456-1460. PubMed ID: 31175013
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis.
Vannella L; Lahner E; Osborn J; Bordi C; Miglione M; Delle Fave G; Annibale B
Aliment Pharmacol Ther; 2010 May; 31(9):1042-50. PubMed ID: 20175768
[TBL] [Abstract][Full Text] [Related]
12. Cost of detecting gastric neoplasia by surveillance endoscopy in atrophic gastritis in Italy: A low risk country.
Lahner E; Hassan C; Esposito G; Carabotti M; Zullo A; Dinis-Ribeiro M; Annibale B
Dig Liver Dis; 2017 Mar; 49(3):291-296. PubMed ID: 28034664
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.
Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Berretti D; Castellani D; Cacciari G; Fazio N; Colao A; Ferone D; Tomassetti P
Endocrine; 2016 Jan; 51(1):131-9. PubMed ID: 25814125
[TBL] [Abstract][Full Text] [Related]
14. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
Trinh VQ; Shi C; Ma C
Histopathology; 2020 Dec; 77(6):865-876. PubMed ID: 32702178
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
16. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis.
Borch K; Stridsberg M; Burman P; Rehfeld JF
Scand J Gastroenterol; 1997 Mar; 32(3):198-202. PubMed ID: 9085454
[TBL] [Abstract][Full Text] [Related]
17. Atrophic and Metaplastic Progression in the Background Mucosa of Patients with Gastric Adenoma.
Na HK; Cho CJ; Bae SE; Lee JH; Park YS; Ahn JY; Kim DH; Choi KD; Song HJ; Lee GH; Jang SJ; Jung HY
PLoS One; 2017; 12(1):e0169456. PubMed ID: 28072871
[TBL] [Abstract][Full Text] [Related]
18. [Chronic atrophic gastritis as a precursor to gastric carcinoma].
Blanusa V; Matarić T; Masić A
Med Pregl; 1994; 47(7-8):263-5. PubMed ID: 7791680
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune metaplastic atrophic gastritis and association with neuroendocrine tumors of the stomach.
Nehme F; Rowe K; Palko W; Tofteland N; Salyers W
Clin J Gastroenterol; 2020 Jun; 13(3):299-307. PubMed ID: 31782113
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
